Denosumab: In Cancer Treatment-Induced Bone Loss

Author： Muir Victoria J. Scott Lesley J.

ISSN： 1173-8804

Source： BioDrugs, Vol.24, Iss.6, 2010-12, pp. : 379-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ixabepilone‐induced mitochondria and sensory axon loss in breast cancer patients

Annals Of Clinical And Translational Neurology, Vol. 1, Iss. 9, 2014-09 ,pp. : 639-649

John Wiley & Sons Inc

Access to resources Recommend Favorite

Denosumab in the Prevention of Skeletal-Related Events in Patients with Bone Metastases from Solid Tumors†: Profile Report

By Scott Lesley J. Muir Victoria J.

BioDrugs, Vol. 25, Iss. 6, 2011-12 ,pp. : 397-400

Adis International

Access to resources Recommend Favorite

Spotlight on Denosumab in Postmenopausal Osteoporosis†

By Moen Marit D. Keam Susan J.

BioDrugs, Vol. 25, Iss. 4, 2011-08 ,pp. : 261-264

Adis International

Access to resources Recommend Favorite

Drug-Induced Urticaria: Recognition and Treatment

By Shipley D. Ormerod A.D.

American Journal of Clinical Dermatology, Vol. 2, Iss. 3, 2001-03 ,pp. : 151-158

Adis International

Access to resources Recommend Favorite

Role of Imiquimod in Skin Cancer Treatment

By Mirjana Urosevic Reinhard Dummer

American Journal of Clinical Dermatology, Vol. 5, Iss. 6, 2004-01 ,pp. : 453-458

Adis International

Access to resources Recommend Favorite